Rodríguez-Zúńiga LM, Salgado-Flores L

Language: Spanish
References: 5
Page: 159-161
PDF size: 199.80 Kb.

ABSTRACT

Cytomegalovirus (CMV) infection is a complication in kidney transplant patients. It presents in the first year post-transplant and when it appears it has complications in the patient and the graft, and it presents in the form of CMV infection or disease. Universal prophylaxis and advance therapy have decreased the risk of CMV. Aspergillus spp. infections are mainly pulmonary invasive. Aspergillosis is a diagnostic and therapeutic problem in transplant patients. The determination of the galactomannan antigen of Aspergillus spp. is useful in early diagnosis.

REFERENCES

1. Sagedal S, Nordal KP, Hartmann A et al. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant. 2002; 2 (9): 850-856.

2. Karacan O, Akcay S, Eyubohlu FO et al. Solid organ transplant alicilarinda invaziv pulmoner aspergillozis [Invasive pulmonary aspergillosis in solid organ transplant recipients]. Tuberk Toraks. 2003; 51 (2): 177-182.

3. Gupta A, Khaira A, Lata S et al. Primary cutaneous aspergillosis in renal transplant recipient. Saudi J Kidney Dis Transpl. 2009; 20 (5): 848-849.

4. Kato K, Nagao M, Yunoki T et al. Itraconazole prophylaxis for invasive aspergillus infection in lung transplantation. Transpl Infect Dis. 2014; 16 (2): 340-343.

5. Razonable RR, Humar A; AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplantation. Am J Transplant. 2013; 13 Suppl 4: 93-106.